Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells

Experimental and Molecular Pathology

Volumn 86, Issue 2, 2009, Pages 87-94

  Fosbrink, Matthew ^a   Cudrici, Cornelia ^a   Tegla, Cosmin A ^a   Soloviova, Kateryna ^a   Ito, Takahiro ^a   Vlaicu, Sonia ^a   Rus, Violeta ^a   Niculescu, Florin ^a   Rus, Horea ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VAMHCS   (United States)

Author keywords

Akt; C5b 9; Complement activation; Endothelial cells; RGC 32

Indexed keywords

COMPLEMENT; COMPLEMENT 32; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLIN DEPENDENT KINASE 1; DNA; GROWTH FACTOR; MESSENGER RNA; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN PHOSPHORYLATION;

ADULT; ANGIOGENESIS INDUCING AGENTS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL CYCLE PROTEINS; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 62949147194     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.12.005     Document Type: Article

References (34)

1. Badea T., Niculescu F., Soane L., Fosbrink M., Sorana H., Rus V., Shin M.L., and Rus H. RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J. Biol. Chem. 277 (2002) 502-508
2. Badea T.C., Niculescu F.I., Soane L., Shin M.L., and Rus H. Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. J. Biol. Chem. 273 (1998) 26977-26981
3. Bazzoni G., and Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84 (2004) 869-901
4. Benzaquen L.R., Nicholson-Weller A., and Halperin J.A. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J. Exp. Med. 179 (1994) 985-992
5. Carney D.F., Koski C.L., and Shin M.L. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. J. Immunol. 134 (1985) 1804-1809
6. Carney D.F., Lang T.J., and Shin M.L. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J. Immunol. 145 (1990) 623-629
7. Cunningham K.S., and Gotlieb A.I. The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest. 85 (2005) 9-23
8. Donninger H., Bonome T., Radonovich M., Pise-Masison C.A., Brady J., Shih J.H., Barrett J.C., and Birrer M.J. Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene 23 (2004) 8065-8077
9. Dutta A., and Stillman B. cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication. EMBO J. 11 (1992) 2189-2199
10. Fosbrink M., Badea T., Shin M.L., and Rus H. Regulation of RGC-32 mRNA expression by terminal complement complex C5b-9 and growth factors. FASEB J. 17 (2003) 323
11. Fosbrink M., Cudrici C., Niculescu F., Badea T.C., David S., Shamsuddin A., Shin M.L., and Rus. Overexpression of RGC-32 in colon cancer and other tumors. Exp. Mol. Pathol. 78 (2005) 116-122
12. Fosbrink M., Niculescu F., Rus V., Shin M.L., and Rus H. C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J. Biol. Chem. 281 (2006) 19009-19018
13. Fujimoto N., Igarashi K., Kanno J., Honda H., and Inoue T. Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis. J. Steroid. Biochem. Mol. Biol. 91 (2004) 121-129
14. Furukawa Y., Piwnica-Worms H., Ernst T.J., Kanakura Y., and Griffin J.D. cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science 250 (1990) 805-808
15. Herrmann J., Lerman L.O., Mukhopadhyay D., Napoli C., and Lerman A. Angiogenesis in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1948-1957
16. Hila, S., Soane, L. and Koski, C. L., 2001. Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD. Glia 36, 58-67.
17. James E.R., Fresco V.M., and Robertson L.L. Glucocorticoid-induced changes in the global gene expression of lens epithelial cells. J. Ocul. Pharmacol. Ther. 21 (2005) 11-27
18. Khurana R., Moons L., Shafi S., Luttun A., Collen D., Martin J.F., Carmeliet P., and Zachary I.C. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 111 (2005) 2828-2836
19. Libby P., Aikawa M., and Jain M.K. Vascular endothelium and atherosclerosis. Handb. Exp. Pharmacol. (2006) 285-306
20. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method. Methods 25 (2001) 402-408
21. Moore J.D., Kirk J.A., and Hunt T. Unmasking the S-phase-promoting potential of cyclin B1. Science 300 (2003) 987-990
22. Niculescu F., Badea T., and Rus H. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 142 (1999) 47-56
23. Niculescu F., and Rus H. Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells. Immunol. Res. 24 (2001) 191-199
24. Niculescu F., Rus H., and Shin M.L. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J. Biol. Chem. 269 (1994) 4417-4423
25. Niculescu F., Rus H., van Biesen T., and Shin M.L. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. J. Immunol. 158 (1997) 4405-4412
26. Rus H.G., Niculescu F., and Shin M.L. Sublytic complement attack induces cell cycle in oligodendrocytes. J. Immunol. 156 (1996) 4892-4900
27. Rus H.G., Vlaicu R., and Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127 (1996) 263-271
28. Sagiv E., Memeo L., Karin A., Kazanov D., Jacob-Hirsch J., Mansukhani M., Rechavi G., Hibshoosh H., and Arber N. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 131 (2006) 630-639
29. Schober A., Manka D., von Hundelshausen P., Huo Y., Hanrath P., Sarembock I.J., Ley K., and Weber C. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106 (2002) 1523-1529
30. Scolding N.J., Morgan B.P., Houston W.A., Linington C., Campbell A.K., and Compston D.A. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 339 (1989) 620-622
31. 1-phase progression. Genes Dev. 13 (1999) 1501-1512
32. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., Madge L.A., Schechner J.S., Schwabb M.B., Polverini P.J., and Flores-Riveros J.R. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683-1686
33. Vlaicu S.I., Cudrici C., Ito T., Fosbrink M., Tegla C.A., Rus V., Mircea P.A., and Rus H. Role of response gene to complement 32 in diseases. Arch. Immunol. Ther. Exp. 56 (2008) 115-122
34. Ziche M., Maglione D., Ribatti D., Morbidelli L., Lago C.T., Battisti M., Paoletti I., Barra A., Tucci M., Parise G., Vincenti V., Granger H.J., Viglietto G., and Persico M.G. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab. Invest. 76 (1997) 517-531